Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (DOC) AI Stock Analysis

• Market Cap: AU$53.17M
• Dividend Yield: N/A
• Average Volume (3M): 189.26K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.88
• Revenue Growth: 5.67%
• EPS Growth: N/A
• Country: AU
• Employees: 610
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.02
• Shares Outstanding: 366,642,240
• 10 Day Avg. Volume: 256,148
• 30 Day Avg. Volume: 189,260
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$0.12
• Price Target Upside: -14.29% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 57 Neutral
• Price Target: AU$0.00 ▼(-100.00% Downside)

The overall stock score of 57 reflects a mixed outlook. The technical analysis is the strongest positive factor, showing bullish momentum. However, this is offset by significant financial challenges and a poor valuation. While the company is showing some operational improvements, financial instability and lack of profitability remain major concerns.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Business Overview & Revenue Model

Company Description

Doctor Care Anywhere Group PLC is a telehealth company operating primarily in the healthcare sector. The company provides a digital platform that offers virtual consultations, digital health assessments, and personalized healthcare plans through its network of qualified healthcare professionals. By leveraging technology, Doctor Care Anywhere aims to make healthcare more accessible and convenient for patients, enhancing the overall healthcare experience.

How the Company Makes Money

Doctor Care Anywhere Group PLC generates revenue by offering subscription-based services to patients and healthcare providers. The company earns money through fees charged for virtual consultations and telehealth services provided via its digital platform. Additionally, Doctor Care Anywhere partners with insurance companies and corporate clients to integrate its services into employee health plans, thereby broadening its user base and enhancing its revenue streams. The company may also generate income through strategic partnerships with healthcare organizations and technology providers to expand its service offerings and improve its platform capabilities.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Financial Statement Overview

Summary

Doctor Care Anywhere Group PLC exhibits strong revenue and gross profit growth, indicating potential for future profitability. However, persistent net losses and negative equity highlight ongoing financial challenges. The high leverage and negative equity position present significant financial risks. Cash flow improvements are a positive sign, but more progress is needed to ensure long-term financial health and stability.

Income Statement

The company has shown a significant improvement in its revenue growth, increasing from $30.42M in 2022 to $39.33M in 2024, marking a growth trend. The Gross Profit has also increased, but the company is still operating at a loss with a Net Income of -$6.29M in 2024, though this is an improvement from -$22.03M in 2022. EBIT and EBITDA have also improved but remain negative, indicating ongoing operational challenges. Overall, the revenue growth and gross profit improvements are positive, but persistent net losses and negative operating margins indicate ongoing profitability challenges.

Balance Sheet

The balance sheet reveals a negative Stockholders' Equity of -$0.65M in 2024, indicating potential financial instability. The Debt-to-Equity ratio is not meaningful due to negative equity, and the company has a high level of debt ($8.27M) relative to its assets ($14.99M), indicating high leverage. The equity ratio is negative, highlighting financial distress. Despite a reduction in debt from 2023, the negative equity position poses a significant risk.

Cash Flow

Free Cash Flow improved from -$24.38M in 2022 to $0.347M in 2024, indicating improved cash management. The Operating Cash Flow turned positive in 2024 at $0.353M, showing a recovery from previous years' negative cash flows. However, the Free Cash Flow to Net Income ratio remains low, and while operational cash flow has improved, the company's cash position needs further strengthening to ensure sustainability.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	39.33M	38.46M	30.42M	13.74M	―
Gross Profit	22.42M	17.69M	13.42M	―	―
EBITDA	-2.15M	-8.35M	-22.21M	-10.95M	―
Net Income	-6.29M	-10.05M	-22.03M	-10.86M	-17.61M
Balance Sheet
Total Assets	14.99M	19.61M	22.01M	19.69M	27.84M
Cash, Cash Equivalents and Short-Term Investments	5.29M	8.10M	5.41M	―	21.60M
Total Debt	8.27M	10.79M	1.72M	―	―
Total Liabilities	15.64M	17.27M	9.72M	―	―
Stockholders Equity	-645.00K	2.33M	12.29M	15.82M	25.04M
Cash Flow
Free Cash Flow	347.00K	-8.67M	-24.38M	-10.10M	―
Operating Cash Flow	353.00K	-6.34M	-22.03M	―	―
Investing Cash Flow	-1.65M	-2.24M	-2.34M	―	―
Financing Cash Flow	-332.00K	9.32M	5.90M	―	26.35M

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.14
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DOC, the sentiment is Positive. The current price of 0.14 is above the 20-day moving average (MA) of 0.13, above the 50-day MA of 0.12, and above the 200-day MA of 0.09, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.42 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:DOC.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DOC	57 Neutral	AU$53.17M	―	-652.32%	―	5.67%	―
MDR	56 Neutral	AU$40.02M	110.00	-8.34%	―	-5.27%	50.29%
PCK	55 Neutral	AU$76.25M	―	-457.46%	―	21.93%	10.34%
Sector *	50 Neutral	AU$2.58B	3.16	5.87%	2.68%	36.95%	13.61%
EMD	50 Neutral	AU$25.68M	―	-74.80%	―	-9.16%	89.23%
GLH	45 Neutral	AU$5.21M	―		―	-11.00%	86.56%
SHG	40 Underperform	AU$100.47M	―		―	―	―

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Corporate Events

Doctor Care Anywhere Announces September 2025 Australia Investor Roadshow

Doctor Care Anywhere has announced an investor roadshow in Australia from September 15-19, 2025, where CEO Laura O’Riordan and senior management will present the company’s H1 financial results, business updates, and growth strategy. The roadshow, with events in Sydney and Melbourne, provides investors an opportunity to engage directly with the leadership team, offering insights into the company’s direction and allowing for direct interaction and questions.

The most recent analyst rating on (AU:DOC) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Achieves Historic Cash Inflow Milestone in Q2 2025

Doctor Care Anywhere Group PLC reported a significant positive cash inflow of £2.2 million for Q2 2025, marking a historic milestone in its financial performance. The company saw a 1.3% increase in consultations quarter-over-quarter, aligning with management expectations, and continued margin improvements due to cost base transformation and utilization initiatives. With £4.8 million in cash on the balance sheet, the company is poised for further growth, supported by new contracts and ongoing initiatives to broaden its care offerings, despite a year-over-year decrease in consultations due to changes in its secondary care pathway.

The most recent analyst rating on (AU:DOC) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere to Release Q2 2025 Performance Report

Doctor Care Anywhere Group PLC announced that it will release its Q2 2025 performance report on 31 July 2025. This upcoming report is expected to provide insights into the company’s operational performance, potentially impacting its market positioning and offering stakeholders a clearer view of its strategic direction.

The most recent analyst rating on (AU:DOC) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Group PLC Announces Cessation of Securities

Doctor Care Anywhere Group PLC announced the cessation of 1,484,770 securities due to the lapse of conditional rights that were not satisfied by the deadline of June 30, 2025. This cessation may impact the company’s capital structure and could influence investor perceptions regarding the company’s ability to meet certain financial conditions.

The most recent analyst rating on (AU:DOC) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Announces Executive Leadership Changes

Doctor Care Anywhere Group PLC has announced key executive changes, with Kathy Cong appointed as the new Company Secretary effective June 30, 2025, succeeding Cathy Baxandall. Kathy brings over 20 years of experience in corporate governance and regulatory compliance. Additionally, Seema Sangar will step down as CFO by the end of July 2025, with Niall Dore taking over as Interim CFO. Niall’s extensive background in financial leadership within digital and technology sectors is expected to bolster the company’s strategic financial initiatives.

The most recent analyst rating on (AU:DOC) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Announces Director’s Acquisition of Share Options

Doctor Care Anywhere Group PLC has announced a significant change in its director’s interest notice, with Director Laura O’Riordan acquiring 30,000,000 options over ordinary shares/CDIs under the company’s Long Term Incentive Plan. This move, approved by shareholders, reflects the company’s strategy to align leadership incentives with long-term growth objectives, potentially impacting its market positioning and stakeholder confidence.

The most recent analyst rating on (AU:DOC) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.